Targeting the transferrin receptor for brain drug delivery

Progress in Neurobiology
Kasper Bendix JohnsenTorben Moos

Abstract

Obtaining efficient drug delivery to the brain remains the biggest challenge for the development of therapeutics to treat diseases of the central nervous system. The main obstacle is the blood-brain barrier (BBB), which impedes the entrance of most molecules present in the systemic circulation, especially large molecule drugs and nanomedicines. To overcome this obstacle, targeting strategies binding to nutrient receptors present at the luminal membrane of the BBB are frequently employed. Amongst the numerous potential targets at the BBB, the transferrin receptor (TfR) remains the most common target used to ensure sufficient drug delivery to the brain. In this review, we provide a full account on the use of the TfR as a target for brain drug delivery by describing the function of the TfR in the BBB, the historical background of its use in drug delivery, and the most recent evidence suggesting TfR-targeted medicines to be efficient for brain drug delivery with a clear clinical potential.

References

Oct 24, 1979·Biochimica Et Biophysica Acta·E H Morgan
Jul 1, 1992·Journal of Neurochemistry·C M MorrisR G Pullen
Nov 1, 1991·Journal of Neurochemistry·E M TaylorE H Morgan
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·P M FridenR M Starzyk
Dec 1, 1990·Journal of Neurochemistry·D C MashW J Weiner
Jul 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J M HillC B Pert
Apr 1, 1987·Physiological Reviews·H A Huebers, C A Finch
Jan 1, 1987·Journal of Neuroscience Research·J B FishmanR E Fine
Mar 29, 1985·Biochemical and Biophysical Research Communications·P W DicksonG Schreiber
Oct 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·B BlochA Kahn
Apr 29, 1967·Nature·S Cohen, C Milstein
Aug 1, 1984·Biology of Reproduction·S R Sylvester, M D Griswold
Nov 8, 1984·Nature·W A JefferiesD Y Mason
May 1, 1983·Journal of Clinical Pathology·K C GatterD Y Mason
Jul 26, 1984·The New England Journal of Medicine·J W Larrick, E S Hyman
Mar 1, 1984·The Biochemical Journal·M K SkinnerM D Griswold
Jul 14, 1995·Brain Research. Developmental Brain Research·T Moos
Mar 1, 1995·Bioconjugate Chemistry·U BickelW M Pardridge
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·S U ShinS L Morrison
Feb 1, 1995·Free Radical Biology & Medicine·S J Stohs, D Bagchi
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·W M PardridgeY S Kang
Oct 1, 1994·Neuropathology and Applied Neurobiology·C M MorrisJ A Edwardson
Oct 1, 1994·Neuropathology and Applied Neurobiology·C M MorrisJ A Edwardson
Nov 1, 1994·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·U BickelW M Pardridge
Dec 1, 1993·The Journal of Comparative Neurology·S A Benkovic, J R Connor
Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·U BickelW M Pardridge
Jan 1, 1995·Acta Neuropathologica·W L dos SantosD K Male
Jul 1, 1996·The Journal of Clinical Investigation·L W KlompJ D Gitlin
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·J HuwylerW M Pardridge
Oct 1, 1996·Nutrition Reviews·J L BeardD J Piñero

❮ Previous
Next ❯

Citations

Jan 10, 2020·Nanomedicine·John Je MulvihillAndreas M Grabrucker
Nov 28, 2019·Drug Delivery and Translational Research·Maria João RamalhoMaria do Carmo Pereira
May 14, 2020·Expert Opinion on Investigational Drugs·Maria B Garcia-FabianiMaria G Castro
Aug 28, 2020·International Journal of Molecular Sciences·Mary J O'Sullivan, Andrew J Lindsay
Sep 29, 2020·International Journal of Nanomedicine·Ping SunWeilin Chen
Mar 7, 2020·Fluids and Barriers of the CNS·Richard F KeepLester R Drewes
Nov 27, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Pawel StockiJ Lynn Rutkowski
Dec 19, 2020·Pharmaceutics·Seigo Kimura, Hideyoshi Harashima
Aug 1, 2020·Advanced Drug Delivery Reviews·Jindřich Kopeček, Jiyuan Yang
Jan 10, 2021·Antioxidants·Pamela J UrrutiaMarco Tulio Núñez
Apr 19, 2020·Journal of Molecular Biology·Zachary R CrookJames M Olson
Mar 10, 2021·Nanoscale Horizons : the Home for Rapid Reports of Exceptional Significance in Nanoscience and Nanotechnolgy·Rui XuQi Shen
Oct 4, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Pengbo GuoHo Lun Wong
Sep 22, 2020·Current Opinion in Chemical Engineering·Alexander G SoretsEthan S Lippmann
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kristen M Tummillo, Karsten R O Hazlett
Apr 2, 2021·Frontiers in Molecular Neuroscience·Kaushik BanerjeeMaria G Castro
Apr 13, 2021·ACS Omega·Tejaswi KoneruArun K Iyer
May 1, 2021·Journal of Clinical Medicine·Shicheng YangSrinivas Sridhar
Apr 30, 2021·International Journal of Pharmaceutics·Renata Ribeiro de CastroBruno Sarmento
Apr 30, 2021·International Journal of Pharmaceutics·Solmaz Mojarad-JabaliHadi Valizadeh
Jun 4, 2021·Fluids and Barriers of the CNS·Rebecca FaresjöStina Syvänen
May 29, 2021·Acta Biomaterialia·Hanmei LiQiang Peng
Jul 14, 2021·Nature Reviews. Clinical Oncology·Patricia S Steeg
Aug 10, 2021·International Journal of Pharmaceutics·Qing-Hua LanQing Yao
Dec 5, 2021·AAPS PharmSciTech·Nkafu Bechem NdemazieEdward Agyare
Jul 7, 2021·Nature Communications·Krzysztof KucharzMartin Johannes Lauritzen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.